Clinical Trials Logo

Clinical Trial Summary

A prospective, blinded multicenter study for evaluation of chest pain patients with severe coronary calcium (Agatston score > 399). The objective is to evaluate if an initial non-invasive strategy with coronary computed tomography angiography (CCTA) including functional flow reserve derived from CCTA (FFR-CT) is as effective as invasive coronary angiography (ICA) including functional flow reserve (FFR) for the detection and exclusion of obstructive coronary artery disease (CAD). Study hypothesis: initial non-invasive anatomic and functional testing is non-inferior to an invasive anatomic and functional testing strategy.


Clinical Trial Description

Prospective, blinded multicenter study evaluating the diagnostic performance of coronary computed tomography angiography (CCTA) including functional flow reserve derived from CCTA (FFR-CT) for the detection and exclusion of significant obstructive coronary artery disease (CAD). The reference standard vil be invasive coronary angiography (ICA) including functional flow reserve (FFR). Patients referred for elective CCTA because of suspected stable CAD are considered. If the initial routine non-enhanced CT scan shows an Agatston score > 399, the patient is eligible for study inclusion. Four sites in the region of Southern Denmark will participate (Odense University Hospital, Svendborg Hospital, Vejle Hospital and Esbjerg Hospital). A total of 278 patients will be included. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03548753
Study type Observational
Source Odense University Hospital
Contact
Status Completed
Phase
Start date September 2, 2016
Completion date April 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01168570 - Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level N/A
Completed NCT03138772 - Tracking CF Lung Disease Through the Early Years: Utility of the LCI
Completed NCT00233649 - DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines Phase 4
Recruiting NCT03728829 - Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Completed NCT00745966 - Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder N/A
Recruiting NCT03253536 - Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma N/A
Not yet recruiting NCT05693714 - Adenovirus Infection in Children With Autoimmune Hepatitis
Completed NCT02922205 - Stapler Post-market Observational Study